Montelukast Sodium

Product NDC: 55111-763
11-digit product format: 551110763
Labeler code: 55111
Product ID: 55111-763_1d9ac31e-956b-897f-2d41-da76d70dd40c
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Montelukast Sodium
Dosage form: GRANULE
Route: ORAL
Labeler: Dr.Reddy's Laboratories Limited
Application: ANDA202906
Marketing category: ANDA
Marketing start: 2012-09-20
Marketing end: 0000-00-00
Substance: MONTELUKAST SODIUM
Active strength: 4 mg/1
Pharmacologic classes: Leukotriene Receptor Antagonist [EPC],Leukotriene Receptor Antagonists [MoA]
NDC exclude flag: No
Listing certified through: 2020-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded product	product	55111-763		I	Inactivated by FDA		2026-10-15
excluded package	package	55111-763	55111-763-03	I	Inactivated by FDA		2026-10-15

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 18 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	55111-763-03	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	55111-763-03	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	55111-763-03	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	55111-763-03	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	55111-763-03	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	55111-763-03	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	55111-763-03	U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	55111-763-03	U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		U	Excluded because listing certification expired	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	55111-763-03	U	Excluded because listing certification expired	`0efc9e666f02…`	`f202fb6c5f17…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 44.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A202906-001	MONTELUKAST SODIUM	MONTELUKAST SODIUM	EQ 4MG BASE/PACKET	GRANULE / ORAL	AB		2012-09-17

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-product	TE code
A202906-001	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 44 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-10-15 13:18:30	2026-09	A202906-001	MONTELUKAST SODIUM	EQ 4MG BASE/PACKET	GRANULE / ORAL	AB	2012-09-17	`c2088c7a36db…`
2026-09-14 22:38:34	2026-08	A202906-001	MONTELUKAST SODIUM	EQ 4MG BASE/PACKET	GRANULE / ORAL	AB	2012-09-17	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	A202906-001	MONTELUKAST SODIUM	EQ 4MG BASE/PACKET	GRANULE / ORAL	AB	2012-09-17	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A202906-001	MONTELUKAST SODIUM	EQ 4MG BASE/PACKET	GRANULE / ORAL	AB	2012-09-17	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A202906-001	MONTELUKAST SODIUM	EQ 4MG BASE/PACKET	GRANULE / ORAL	AB	2012-09-17	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A202906-001	MONTELUKAST SODIUM	EQ 4MG BASE/PACKET	GRANULE / ORAL	AB	2012-09-17	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A202906-001	MONTELUKAST SODIUM	EQ 4MG BASE/PACKET	GRANULE / ORAL	AB	2012-09-17	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A202906-001	MONTELUKAST SODIUM	EQ 4MG BASE/PACKET	GRANULE / ORAL	AB	2012-09-17	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A202906-001	MONTELUKAST SODIUM	EQ 4MG BASE/PACKET	GRANULE / ORAL	AB	2012-09-17	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A202906-001	MONTELUKAST SODIUM	EQ 4MG BASE/PACKET	GRANULE / ORAL	AB	2012-09-17	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A202906-001	MONTELUKAST SODIUM	EQ 4MG BASE/PACKET	GRANULE / ORAL	AB	2012-09-17	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A202906-001	MONTELUKAST SODIUM	EQ 4MG BASE/PACKET	GRANULE / ORAL	AB	2012-09-17	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A202906-001	MONTELUKAST SODIUM	EQ 4MG BASE/PACKET	GRANULE / ORAL	AB	2012-09-17	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A202906-001	MONTELUKAST SODIUM	EQ 4MG BASE/PACKET	GRANULE / ORAL	AB	2012-09-17	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A202906-001	MONTELUKAST SODIUM	EQ 4MG BASE/PACKET	GRANULE / ORAL	AB	2012-09-17	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A202906-001	MONTELUKAST SODIUM	EQ 4MG BASE/PACKET	GRANULE / ORAL	AB	2012-09-17	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A202906-001	MONTELUKAST SODIUM	EQ 4MG BASE/PACKET	GRANULE / ORAL	AB	2012-09-17	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A202906-001	MONTELUKAST SODIUM	EQ 4MG BASE/PACKET	GRANULE / ORAL	AB	2012-09-17	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A202906-001	MONTELUKAST SODIUM	EQ 4MG BASE/PACKET	GRANULE / ORAL	AB	2012-09-17	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A202906-001	MONTELUKAST SODIUM	EQ 4MG BASE/PACKET	GRANULE / ORAL	AB	2012-09-17	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A202906-001	MONTELUKAST SODIUM	EQ 4MG BASE/PACKET	GRANULE / ORAL	AB	2012-09-17	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A202906-001	MONTELUKAST SODIUM	EQ 4MG BASE/PACKET	GRANULE / ORAL	AB	2012-09-17	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A202906-001	MONTELUKAST SODIUM	EQ 4MG BASE/PACKET	GRANULE / ORAL	AB	2012-09-17	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A202906-001	MONTELUKAST SODIUM	EQ 4MG BASE/PACKET	GRANULE / ORAL	AB	2012-09-17	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A202906-001	MONTELUKAST SODIUM	EQ 4MG BASE/PACKET	GRANULE / ORAL	AB	2012-09-17	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A202906-001	MONTELUKAST SODIUM	EQ 4MG BASE/PACKET	GRANULE / ORAL	AB	2012-09-17	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A202906-001	MONTELUKAST SODIUM	EQ 4MG BASE/PACKET	GRANULE / ORAL	AB	2012-09-17	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A202906-001	MONTELUKAST SODIUM	EQ 4MG BASE/PACKET	GRANULE / ORAL	AB	2012-09-17	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A202906-001	MONTELUKAST SODIUM	EQ 4MG BASE/PACKET	GRANULE / ORAL	AB	2012-09-17	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A202906-001	MONTELUKAST SODIUM	EQ 4MG BASE/PACKET	GRANULE / ORAL	AB	2012-09-17	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A202906-001	MONTELUKAST SODIUM	EQ 4MG BASE/PACKET	GRANULE / ORAL	AB	2012-09-17	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A202906-001	MONTELUKAST SODIUM	EQ 4MG BASE/PACKET	GRANULE / ORAL	AB	2012-09-17	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A202906-001	MONTELUKAST SODIUM	EQ 4MG BASE/PACKET	GRANULE / ORAL	AB	2012-09-17	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A202906-001	MONTELUKAST SODIUM	EQ 4MG BASE/PACKET	GRANULE / ORAL	AB	2012-09-17	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A202906-001	MONTELUKAST SODIUM	EQ 4MG BASE/PACKET	GRANULE / ORAL	AB	2012-09-17	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A202906-001	MONTELUKAST SODIUM	EQ 4MG BASE/PACKET	GRANULE / ORAL	AB	2012-09-17	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A202906-001	MONTELUKAST SODIUM	EQ 4MG BASE/PACKET	GRANULE / ORAL	AB	2012-09-17	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	A202906-001	MONTELUKAST SODIUM	EQ 4MG BASE/PACKET	GRANULE / ORAL	AB	2012-09-17	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	A202906-001	MONTELUKAST SODIUM	EQ 4MG BASE/PACKET	GRANULE / ORAL	AB	2012-09-17	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A202906-001	MONTELUKAST SODIUM	EQ 4MG BASE/PACKET	GRANULE / ORAL	AB	2012-09-17	`3a93d1ddd44b…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 44 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-10-15 13:18:30	2026-09	A202906-001	AB	1	`c2088c7a36db…`
2026-09-14 22:38:34	2026-08	A202906-001	AB	1	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	A202906-001	AB	1	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A202906-001	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A202906-001	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A202906-001	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A202906-001	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A202906-001	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A202906-001	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A202906-001	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A202906-001	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A202906-001	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A202906-001	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A202906-001	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A202906-001	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A202906-001	AB	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A202906-001	AB	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A202906-001	AB	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A202906-001	AB	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A202906-001	AB	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A202906-001	AB	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A202906-001	AB	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A202906-001	AB	1	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A202906-001	AB	1	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A202906-001	AB	1	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A202906-001	AB	1	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A202906-001	AB	1	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A202906-001	AB	1	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A202906-001	AB	1	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A202906-001	AB	1	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A202906-001	AB	1	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A202906-001	AB	1	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A202906-001	AB	1	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A202906-001	AB	1	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A202906-001	AB	1	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A202906-001	AB	1	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A202906-001	AB	1	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	A202906-001	AB	1	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	A202906-001	AB	1	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A202906-001	AB	1	`3a93d1ddd44b…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
a62a50ac-1535-4461-9768-8ae703e2e9fb	Product name	1	20210525
8d8a355b-240d-8c38-7331-c9e3c1068a33	Product name	9	20161220
9514609b-a2a9-f8ec-6ba6-3f8e5ee89877	Product name	1	20140508
bc07ef78-e82d-0c19-31f4-31f263780582	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
55111-763-03	2025-01-30	C162847	48780-1	2cef2736-5f2d-d83d-e063-dadaa90ab31f	These highlights do not include all the information needed to use MONTELUKAST SODIUM ORAL GRANULES safely and effectively. See full prescribing information for MONTELUKAST SODIUM ORAL GRANULES . MONTELUKAST SODIUM oral granules, for oral use Initial U.S. Approval: 1998

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
55111-763-03	Montelukast Sodium	30 in 1 CARTON	GRANULE	30		15
55111-763-07	Montelukast Sodium	500 in 1 PACKET	GRANULE	500		15

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
55111-763-03	EA - Each	55111-763	569ceb14-5889-4aeb-804d-5c1cac519e04	1	2013-02-13
55111-763-07	EA - Each	55111-763	ef749b31-25f5-4d9c-a7e2-3dadf931d5bf	1	2013-02-13

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
Montelukast Sodium	ACTIVE INGREDIENT	U1O3J18SFL	MONTELUKAST SODIUM GRANULE [DR.REDDY'S LABORATORIES LIMITED]	12
montelukast	ACTIVE MOIETY	MHM278SD3E	MONTELUKAST SODIUM GRANULE [DR.REDDY'S LABORATORIES LIMITED]	12
HYPROMELLOSE 2910 (3 MPA.S)	INACTIVE INGREDIENT	0VUT3PMY82	MONTELUKAST SODIUM GRANULE [DR.REDDY'S LABORATORIES LIMITED]	12
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	MONTELUKAST SODIUM GRANULE [DR.REDDY'S LABORATORIES LIMITED]	12
MANNITOL	INACTIVE INGREDIENT	3OWL53L36A	MONTELUKAST SODIUM GRANULE [DR.REDDY'S LABORATORIES LIMITED]	12

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
55111-763	MONTELUKAST SODIUM GRANULE [DR.REDDY'S LABORATORIES LIMITED]	15	Legacy NDC, 2 package rows	20190920_3d3df874-d710-7fa4-bb21-434977518337.zip

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
U1O3J18SFL	MONTELUKAST SODIUM	151767-02-1	MONTELUKAST SODIUM

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
351246	montelukast sodium 4 MG Oral Granules	PSN	3d3df874-d710-7fa4-bb21-434977518337	15
351246	montelukast 4 MG Oral Granules	SCD	3d3df874-d710-7fa4-bb21-434977518337	15
351246	montelukast 4 MG (as montelukast sodium 4.2 MG) Oral Granules	SY	3d3df874-d710-7fa4-bb21-434977518337	15

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
55111-763-03	55111076303	30 PACKET in 1 CARTON (55111-763-03) > 500 GRANULE in 1 PACKET (55111-763-07)	30 packet	2012-09-20	0000-00-00	No	No	Current
55111-763-07	55111076307	500 in 1 PACKET						Historical

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Montelukast Sodium - Dr.Reddy's Laboratories Limited \| Dr.Reddy's Laboratories Limited-FTO3	Dr.Reddy's Laboratories Limited \| Dr.Reddy's Laboratories Limited-FTO3	2019-08-30	HUMAN PRESCRIPTION DRUG LABEL	15